Targeting the DNA Damage Response for Anti-Cancer Therapy

Nonfiction, Health & Well Being, Medical, Medical Science, Genetics, Specialties, Oncology
Cover of the book Targeting the DNA Damage Response for Anti-Cancer Therapy by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319758367
Publisher: Springer International Publishing Publication: May 26, 2018
Imprint: Humana Language: English
Author:
ISBN: 9783319758367
Publisher: Springer International Publishing
Publication: May 26, 2018
Imprint: Humana
Language: English

Over the past decade a complex role for DNA damage response (DDR) in tumorigenesis has emerged. A proficient DDR has been shown to be a primary cause for cellular resistance to the very many DNA damaging drugs, and IR, that are widely used as standard-of-care across multiple cancer types. It has also been shown that defects in this network, predominantly within the ATM mediated signaling pathway, are commonly observed in cancers and may be a primary event during tumorigenesis. Such defects may promote a genomically unstable environment, facilitating the persistence of mutations, any of which may provide a growth or survival advantage to the developing tumor. In addition, these somatic defects provide opportunities to exploit a reliance on remaining repair pathways for survival, a process which has been termed synthetic lethality. As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents that may have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR.

In this book we will review a series of important topics that are of great interest to a broad range of academic, industrial and clinical researchers, including  the basic science of the DDR, its role in tumorigenesis and in dictating response to DNA damaging drugs and IR. Additionally, we will focus on the several proteins that have been targeted in attempts to provide drug candidates, each of which appear to have quite distinct profiles and could represent very different opportunities to provide patient benefit.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Over the past decade a complex role for DNA damage response (DDR) in tumorigenesis has emerged. A proficient DDR has been shown to be a primary cause for cellular resistance to the very many DNA damaging drugs, and IR, that are widely used as standard-of-care across multiple cancer types. It has also been shown that defects in this network, predominantly within the ATM mediated signaling pathway, are commonly observed in cancers and may be a primary event during tumorigenesis. Such defects may promote a genomically unstable environment, facilitating the persistence of mutations, any of which may provide a growth or survival advantage to the developing tumor. In addition, these somatic defects provide opportunities to exploit a reliance on remaining repair pathways for survival, a process which has been termed synthetic lethality. As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents that may have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR.

In this book we will review a series of important topics that are of great interest to a broad range of academic, industrial and clinical researchers, including  the basic science of the DDR, its role in tumorigenesis and in dictating response to DNA damaging drugs and IR. Additionally, we will focus on the several proteins that have been targeted in attempts to provide drug candidates, each of which appear to have quite distinct profiles and could represent very different opportunities to provide patient benefit.

More books from Springer International Publishing

Cover of the book Posttraumatic Stress Disorder and Related Diseases in Combat Veterans by
Cover of the book Countdown to a Moon Launch by
Cover of the book Chinese Global Production Networks in ASEAN by
Cover of the book Moral Equality, Bioethics, and the Child by
Cover of the book Host Plants of World Agrilus (Coleoptera, Buprestidae) by
Cover of the book Adam Smith’s Moral Sentiments in Vanity Fair by
Cover of the book The Surgical Management of the Diabetic Foot and Ankle by
Cover of the book Positron Emission Tomography with Computed Tomography (PET/CT) by
Cover of the book Induction Chemotherapy by
Cover of the book Well-Being in the Information Society. Fighting Inequalities by
Cover of the book Proximal Humerus Fractures by
Cover of the book Porous Carbons – Hyperbranched Polymers – Polymer Solvation by
Cover of the book Resilient Computer System Design by
Cover of the book Wilhelm Ostwald by
Cover of the book Urological Cancer Management by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy